Shandong Weigao repurchases shares, boosting treasury holdings

Shandong Weigao Group Medical Polymer Company Limited (01066) repurchased 100,000 H-shares on November 20, 2025. These shares were bought on the Exchange at prices ranging from HK$5.33 to HK$5.34, with an aggregate price paid of HK$533,600. Following the repurchase, the company's issued shares (excluding treasury shares) decreased by 100,000 to 4,496,297,924, representing a 0.0022% change.

The repurchased shares are now held as treasury shares, increasing the total number of treasury shares from 25,934,400 to 26,034,400. The total number of issued shares remained at 4,522,332,324. The repurchase was conducted under a mandate granted on May 27, 2025, which authorised the repurchase of 451,560,392 shares.

As of the repurchase date, 19,386,000 shares have been repurchased under this mandate. This represents 4.2931% of the number of issued shares (excluding treasury shares) as at the date of the resolution. A moratorium period for new share issues or treasury share sales is in effect until December 19, 2025.